Novel Spectacle Lenses for Near-sightedness
(CHERRY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any safety data available for Novel Spectacle Lenses?
What makes the Novel Spectacle Lens treatment unique for near-sightedness?
The Novel Spectacle Lens treatment is unique because it incorporates lenslets in its design, which helps control myopia (near-sightedness) by creating myopic defocus and contrast modulation. This approach is different from traditional lenses, which do not use lenslets to manage the progression of near-sightedness.678910
What data supports the effectiveness of the treatment Novel Spectacle Lens for near-sightedness?
Research shows that spectacle lenses with aspherical lenslets, similar to the Novel Spectacle Lens, have been effective in slowing the progression of myopia (near-sightedness) in clinical trials. These lenses, like the defocus incorporated multiple segments (DIMS) lenses, have demonstrated significant results in controlling myopia.511121314
Who Is on the Research Team?
Lyndon Jones, PhD, FCoptom
Principal Investigator
Centre for Ocular Research & Education, Canada
Jill Woods, BSc, MCOptom
Principal Investigator
Centre for Ocular Research & Education, Canada
Are You a Good Fit for This Trial?
This trial is for individuals already enrolled in the CPRO-1802-001 study who have near-sightedness, including degenerative or progressive myopia. Participants must be minors who've given their assent and whose parents or guardians have signed a consent letter. Those with temporary health issues affecting the eyes like colds, allergies, or fatigue cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants wear novel spectacle lenses designed to inhibit myopia progression
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Novel Spectacle Lens
Find a Clinic Near You
Who Is Running the Clinical Trial?
SightGlass Vision, Inc.
Lead Sponsor
University of Waterloo
Collaborator